Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $50.8900 (0.89%) ($50.8900 - $50.8900) on Tue. Jul. 26, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.67% (three month average) | RSI | 64 | Latest Price | $50.8900(0.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.3% a day on average for past five trading days. | Weekly Trend | HALO advances 0.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(41%) IWM(36%) IWO(36%) IWN(35%) IFRA(34%) | Factors Impacting HALO price | HALO will decline at least -1.335% in a week (0% probabilities). VIXM(-14%) UUP(-8%) EDOC(-7%) VXX(-6%) TBT(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.335% (StdDev 2.67%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $50.29(1.19%) | 10 Day Moving Average | $49.51(2.79%) | 20 Day Moving Average | $48.53(4.86%) | To recent high | -1.7% | To recent low | 36.2% | Market Cap | $6.955b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |